SINGAPORE - Cell therapy, where living cells are harnessed to treat or prevent disease, is hailed as the future of medicine.Singapore, leveraging on its strong biopharmaceutical manufacturing base, and its early lead in stem cell research, has earmarked cell manufacturing as its next big money spinner.
Biopharmaceutical manufacturing, which is the production of small molecule drugs and biologics such as proteins, is an important sector for Singapore, contributing about 4 per cent of the country's GDP and employing more than 7,700 highly skilled workers.To replicate the success in cell manufacturing would call for advanced technologies and techniques, said A*Star.
In cell therapy, intact living cells are injected, grafted or implanted into a patient to restore tissue or organ function, or fight diseases such as cancer, for instance.Local biotech firm CellResearch Corporation, which is worth $700 million and has 44 patents, is among the handful of home-grown firms that are pioneers in cell therapy.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: The Straits Times - 🏆 8. / 63 Read more »